Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells.
作者信息
Than Hein, Pomicter Anthony D, Yan Dongqing, Beaver Larry P, Eiring Anna M, Heaton William L, Senina Anna, Clair Phillip M, Shacham Sharon, Mason Clinton C, Hare Thomas O', Deininger Michael W
机构信息
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Department of Hematology, Singapore General Hospital, Singapore, Singapore.
出版信息
Leukemia. 2020 Jun;34(6):1679-1683. doi: 10.1038/s41375-020-0708-1. Epub 2020 Jan 24.
Abstract
摘要
相似文献
1
Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells.核输出和Bcr-Abl1的协同抑制选择性地靶向慢性粒细胞白血病干细胞。
Leukemia. 2020 Jun;34(6):1679-1683. doi: 10.1038/s41375-020-0708-1. Epub 2020 Jan 24.
2
Editorial: CML HSCs: Are the True Enemies for the Patient?社论：慢性粒细胞白血病造血干细胞：是患者真正的敌人吗？
Curr Drug Targets. 2017;18(4):376. doi: 10.2174/138945011804170206191356.
3
Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells.MET激活对慢性髓性白血病细胞中BCR-ABL1酪氨酸激酶抑制剂耐药性的作用。
Oncotarget. 2017 Jun 13;8(24):38717-38730. doi: 10.18632/oncotarget.16314.
4
Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation.吡硫翁铂通过依赖去泛素化酶抑制的半胱天冬酶激活和Bcr-Abl下调诱导对伊马替尼耐药的慢性髓性白血病细胞凋亡。
Cell Death Dis. 2017 Jul 6;8(7):e2913. doi: 10.1038/cddis.2017.284.
5
CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation.CD-200可诱导T315I突变的伊马替尼耐药慢性髓性白血病细胞凋亡并抑制Bcr-Abl信号传导。
Int J Oncol. 2015 Jul;47(1):253-61. doi: 10.3892/ijo.2015.2994. Epub 2015 May 11.
6
HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation.HS-543可诱导具有T315I突变的伊马替尼耐药慢性髓性白血病细胞凋亡。
Oncotarget. 2015 Jan 30;6(3):1507-18. doi: 10.18632/oncotarget.2837.
7
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.CM363，一种新型萘醌衍生物，它作为多激酶调节剂，可克服慢性粒细胞白血病中的伊马替尼耐药性。
Oncotarget. 2017 May 2;8(18):29679-29698. doi: 10.18632/oncotarget.11425.
8
Induction of apoptosis in imatinib sensitive and resistant chronic myeloid leukemia cells by efficient disruption of bcr-abl oncogene with zinc finger nucleases.锌指核酸酶有效破坏 bcr-abl 癌基因诱导伊马替尼敏感和耐药慢性髓性白血病细胞凋亡。
J Exp Clin Cancer Res. 2018 Mar 20;37(1):62. doi: 10.1186/s13046-018-0732-4.
9
UV Differentially Induces Oxidative Stress, DNA Damage and Apoptosis in BCR-ABL1-Positive Cells Sensitive and Resistant to Imatinib.紫外线在对伊马替尼敏感和耐药的BCR-ABL1阳性细胞中差异诱导氧化应激、DNA损伤和凋亡。
Int J Mol Sci. 2015 Aug 5;16(8):18111-28. doi: 10.3390/ijms160818111.
10
PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.PBA2，一种针对慢性髓性白血病中伊马替尼耐药的BCR-ABL T315I突变的新型抑制剂。
Cancer Lett. 2016 Dec 28;383(2):220-229. doi: 10.1016/j.canlet.2016.09.025. Epub 2016 Oct 5.
引用本文的文献
1
A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection.全基因组 CRISPR-Cas9 筛选鉴定出 CENPJ 是疟原虫肝脏感染期间改变微管组织的宿主调节剂。
Cell Chem Biol. 2022 Sep 15;29(9):1419-1433.e5. doi: 10.1016/j.chembiol.2022.06.001. Epub 2022 Jun 22.
2
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.MS4A3 通过增强共同β链细胞因子受体内吞作用促进慢性髓性白血病分化。
Blood. 2022 Feb 3;139(5):761-778. doi: 10.1182/blood.2021011802.
Zotero 插件